What does Brexit mean for bioethics?
By Xavier Symons,
BioEdge
| 06. 25. 2016
It is tempting to provide an alarmist answer to this question. Yet it is wise to avoid the apocalyptic tone of recent media coverage and first to flag what is not going to change in UK biomedical ethics policy.
As highlighted by a post on the Christian Medical Fellowship Blogs, the UK will not (or, at least, not yet) be leaving the Council of Europe (CoE) – this entity does not fall under the auspices of the EU. That the UK will remain in the CoE is significant, as this is the umbrella organisation for what is known as the Committee on Bioethics, an influential policy body that seeks to apply principles outlined in the Convention on Human Rights and Medicine to new issues in medical technology and research.
The European Court on Human Rights also falls within the purview of the CoE. Importantly, The ECHR has handed down significant decisions within the area of conscientious objection in healthcare.
Yet some suggest the Brexit vote may effect disability rights legislation and regulations in the UK. EU directives about...
Related Articles
Media coverage of recent developments in embryo gene editing might seem to suggest that gene-edited babies are close to becoming a reality. As tech billionaires eager to profit off of techno-eugenics invest in “designer baby” technologies, attempts to normalize heritable genome editing – which remains unsafe and raises significant ethical and societal concerns – are especially dangerous. It’s worth taking a closer look at these developments and what they mean, in a way that pushes back on narratives normalizing the...
By Roxanne Khamsi, The Atlantic | 07.07.2026
When Ludivine Verboogen and Romain Alderweireldt’s third child was born in Belgium in late 2015, they marveled at his long fingers. Perhaps one day he will be a famous pianist, they thought. But soon Ludivine grew worried that her son...
By Julia Métraux, Mother Jones [cites CGS' Katie Hasson] | 07.07.2026
During his 2015 State of the Union address, then-President Barack Obama announced what he promised would be an ambitious public health project. “Tonight, I’m launching a new Precision Medicine Initiative to bring us closer to curing diseases like cancer and diabetes...
By Michael Le Page , New Scientist | 06.25.2026
We now know the master gene that controls embryonic development in people. Called NANOG, its role has been identified by making precise changes to the DNA of fertilised eggs using a technique called CRISPR base editing.
The discovery might lead...